131I-imatinib

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name131I-imatinib
Drug Alias NameSKI-242
ClassificationOther
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsStem cell growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptorStem cell growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A